Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PRESS SEMINAR
April 5, 2004
- NHI Prices of 35 Unprofitable Products to Be Raised in April
March 29, 2004
- BUSINESS NEWS IN BRIEF
March 29, 2004
- Drug Makers Need Research Tools from Universities: JPMA Symposium
March 29, 2004
- Merck Ltd to Focus on Cancer, Emergency Care
March 29, 2004
- Leading Makers to Obtain Evidence on Their Defensive Factor-enhancing Anti-Ulcer Drugs
March 29, 2004
- 4 Potential Blockbusters in the Pipeline: Eisai
March 29, 2004
- GSK to Strengthen Promotion of Serevent for COPD
March 29, 2004
- Aiming to Be a Global Research-driven Company Based in Japan: Dr Takenaka of Yamanouchi
March 29, 2004
- DIAGNOSTIC NEWS IN BRIEF
March 29, 2004
- Takeda's Income from IP to Exceed \60 Bil. in FY2003
March 29, 2004
- WORLD NEWS IN BRIEF
March 29, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
March 29, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 29, 2004
- American College of Cardiology 53rd Annual Scientific Session
March 29, 2004
- Outsources of Hospital Services Increasing: JHEF Survey
March 29, 2004
- OTC NEWS IN BRIEF
March 29, 2004
- OBITUARY
March 29, 2004
- Switch to GE Injectables to Save \200 Mil. Annually: St. Marianna Univ. Hospital
March 29, 2004
- Clinical Oncologist Certification System to Be Established
March 29, 2004
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…